No Picture
Business

Tariff Shifts Open New Doors for Indian Toy Makers in US Market q3y3i

By – Shobhit Singh, MD & CEO, Stone Sapphire India Pvt. Ltd.  “The changing US tariff scenario is certainly a cause for concern, but it also provides a window of opportunity for Indian producers. In […]

No Picture
Business

StoxBox: Views on Sun Pharma Industries Ltd. Q4 FY24 Result c263g

The pharma giant reported strong financial results in Q4FY24, ed by robust performance in the US and domestic markets. The revenue growth was majorly led by the US market in the March quarter, with the […]

No Picture
news

Vibaantta Global Pvt Ltd Acquires BGE Global Distribution Inc, Expanding Reach into US Market 6l154

New Delhi, 21th March, 2024: Vibaantta Global Private Limited, a prominent player in the rice production and sales sector, has announced its acquisition of BGE Global Distribution Inc, a Florida-based company specializing in the distribution […]

Business

Dr. Reddy’s Laboratories announces the launch of Fenofibrate Tablets USP, in the U.S. Market 622s3p

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Fenofibrate Tablets USP, a therapeutic equivalent generic version of Tricor® […]

Business

Dr. Reddy’s Laboratories announces the launch of Amphetamine Sulfate Tablets USP, in the U.S. Market 1q246m

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Amphetamine Sulfate Tablets USP, a therapeutic equivalent generic version of […]

Business

Dr. Reddy’s Laboratories announces first-to-market launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL 1k3a69

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose […]

Business

Dr. Reddy’s announces the launch of the over-the-counter store brand 4i6h47

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced launch of an over-the-counter (OTC) store-brand equivalent of Mucinex® D Extended Release Tablets […]

Business

Reddy’s Laboratories announces the launch of Tobramycin Inhalation Solution, USP in the U.S. Market 6m6h69

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Tobramycin Inhalation Solution, USP a therapeutic equivalent generic version of […]

Business

Dr. Reddy’s Laboratories announces the launch of Daptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market 1j4r18

Hyderabad, India and Princeton, NJ, USA. May 15, 2019— Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Daptomycin […]